Marketing Your Medical Technology for Outpatient Use: Five Strategies for Success

Profits are shrinking at many U.S. healthcare systems. Their inpatient costs are increasing, while their admissions and revenues remain flat. In response, organizations are shifting their care-delivery strategies away from the costly inpatient setting to more cost-effective outpatient settings. Many companies see this shift and are investing to reflect it. However, simply labeling a product for outpatient use is not enough. In today’s value-based care environment, the bar for outpatient use is even higher than that for inpatient use. The shift in care delivery demands a shift in R&D and marketing. Follow these five strategies to overcome the barriers and create the vital need for your solution. Strategy #1: Demonstrate that it reduces the total cost of care Nearly 150 million Americans have chronic diseases, and those accounted for $1.1 trillion of U.S. healthcare costs in 2016.¹ While prevention is far cheaper than treatment, changing human behavior has proven challenging. Historically, little has been spent on prevention, because its cost savings are hard to determine. That’s why you need to demonstrate how your product, used in an outpatient setting, conclusively reduces the total cost of care. Cost-reduction case: Livongo Health Livongo uses behavioral coaching to reduce the impact of diabetes, the single most expensive chronic disease. Payers have aggressively adopted their solution, the result of a marketing st...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news

Related Links:

Conclusion. Anxiety and mood are potentially modifiable risk factors that have the greatest impact on pre- and postoperative pain. These results can be used to identify higher-risk patients and develop preoperative therapeutic protocols to improve postoperative outcomes. Level of Evidence: 3
Source: Spine - Category: Orthopaedics Tags: DEFORMITY Source Type: research
Conclusion. Patients with higher BMI had lower preoperative PROMIS PF scores and experienced similar improvement in PROMIS PF scores in the postoperative period. This study established that PROMIS PF may be utilized to evaluate the recovery of obese patients following MIS TLIF. Level of Evidence: 3
Source: Spine - Category: Orthopaedics Tags: OUTCOMES Source Type: research
Finding the'missing'people walking around with undiagnosed type 2 diabetes, estimated at around 1 in 70 of the population, will require screening, but the question is how, say experts.Medscape News UK
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
TYPE 1 and type 2 diabetes are two well established conditions that affect a person ’s blood sugar control. But another type of diabetes, type 1.5 diabetes, is beginning to gain traction - what is it, and are you at risk?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
Objective: To examine the association between hearing impairment and cognitive decline and to identify possible risk factors for presbycusis. Study Design: Cross-sectional survey in prospective cohort study. Setting: University hospital. Patients: A total of 322 participants aged>60 years, for whom all the below data were available, were enrolled in the study. There were 168 females and 154 males with a median age of 71 years (range: 60–89 yrs). Interventions: PROST (Project in Sado for Total Health), a medical database in Sado island Japan, was analyzed. Main Outcome Measures: Data on pure-tone a...
Source: Otology and Neurotology - Category: ENT & OMF Tags: SENSORINEURAL HEARING LOSS AND TINNITUS Source Type: research
This article describes the prevalence, identification, and treatment of common comorbid psychological disorders.
Source: Heart Failure Clinics - Category: Cardiology Authors: Source Type: research
Heart failure (HF) and chronic obstructive pulmonary disease (COPD) are both common causes of breathlessness and often conspire to confound accurate diagnosis and optimal therapy. Risk factors (such as aging, smoking, and obesity) and clinical presentation (eg, cough and breathlessness on exertion) can be very similar, but the treatment and prognostic implications are very different. This review discusses the diagnostic challenges in individuals with exertional dyspnea. Also highlighted are the prevalence, clinical relevance, and therapeutic implications of a concurrent diagnosis of COPD and HF.
Source: Heart Failure Clinics - Category: Cardiology Authors: Source Type: research
Sodium-glucose co-transporter 2 (SGLT2) inhibitors have a well-defined safety profile based on data obtained from numerous clinical trials, including cardiovascular outcomes trials (CVOTs) and postmarketing pharmacovigilance reporting. Adverse events including risk of genital mycotic infection and volume depletion-related events are consistent with the mechanism of action of this drug class. However, several emergent (albeit infrequent) serious safety issues have also been reported. In their respective CVOTs, the proportion of patients with reported diabetic ketoacidosis was similar in empagliflozin or canagliflozin compar...
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research
The findings of recent clinical trials have shown that sodium-glucose co-transporter 2 (SGLT2) inhibitors produce effects beyond glucose lowering and have demonstrated beneficial cardiovascular effects that have been observed across a broad range of patients with type 2 diabetes mellitus. In particular, the cardiovascular benefit results largely from substantial and early effects of SGLT2 inhibition on cardiovascular death and hospitalization for heart failure. Recent cardiovascular outcomes trials (CVOTs) have also shown that relative risk reductions in cardiovascular outcomes were observed with SGLT2 inhibition both in p...
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research
More News: Cardiology | Chronic Obstructive Pulmonary | Depression | Diabetes | Diabetes Type 2 | Economics | Endocrinology | Environmental Health | Healthcare Costs | Heart | Insurance | Iron | Marketing | Medical Devices | Nurses | Nursing | Peripheral Vascular Disease (PVD) | Pressure Sores | Rehabilitation | Respiratory Medicine | Sleep Apnea | Sleep Disorders | Sleep Medicine | Study | Ultrasound